Guardant Health
GH
#1169
Rank
โ‚น1.811 T
Marketcap
โ‚น13,391
Share price
-0.52%
Change (1 day)
56.51%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -โ‚น320.40

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น326.18. In 2025 the company made an earnings per share (EPS) of -โ‚น309.35 an increase over its 2024 EPS that were of -โ‚น332.72.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น320.403.57%
2025-โ‚น309.35-7.02%
2024-โ‚น332.72-16.82%
2023-โ‚น400.01-33.13%
2022-โ‚น598.1460%
2021-โ‚น373.8455.04%
2020-โ‚น241.13207.14%
2019-โ‚น78.51-19.81%
2018-โ‚น97.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น23.66-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น228.98-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA